During the past decade, Parkinson's Disease and Movement Disorders Center of Long Island conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 3 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Parkinson's Disease and Movement Disorders Center of Long Island" #1 sponsor was "Impax Laboratories, LLC" with 2 trials, followed by "Annovis Bio Inc." with 1 trials sponsored, "Global Kinetics Corporation" with 1 trials sponsored, "Ipsen" with 1 trials sponsored and "Novartis Pharmaceuticals" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Parkinson's Disease and Movement Disorders Center of Long Island" #1 collaborator was "INC Research Limited" with 1 trials as a collaborator, "Michael J. Fox Foundation for Parkinson's Research" with 1 trials as a collaborator, "Orion Corporation, Orion Pharma" with 1 trials as a collaborator and "TFS Trial Form Support" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Parkinson's Disease and Movement Disorders Center of Long Island" are "Parkinson's Disease" (4 trials), "Parkinson Disease" (1 trials) and "Parkinson's Disease, Idiopathic" (1 trials). Many other conditions were trialed in "Parkinson's Disease and Movement Disorders Center of Long Island" in a lesser frequency.

Most popular intervention types in "Parkinson's Disease and Movement Disorders Center of Long Island" are "Drug" (5 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "IPX066" (2 trials), "Placebo" (2 trials), "Buntanetap" (1 trials), "CLE" (1 trials) and "Carbidopa/levodopa/entacapone" (1 trials). Other intervention names were less common.

The vast majority of trials in "Parkinson's Disease and Movement Disorders Center of Long Island" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Parkinson's Disease and Movement Disorders Center of Long Island". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Parkinson's Disease and Movement Disorders Center of Long Island, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Parkinson's Disease and Movement Disorders Center of Long Island, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".